KBC Group
KOD icon

KBC Group’s Kodiak Sciences KOD Stock Holding History

KBC Group’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Hold
1,014
– – ﹤0.01% 1773
2026
Q1 		$39K Buy
+1,014
New +$26.2K ﹤0.01% 1729

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

KBC Group's KOD Position: Q2 2026 in Review

KBC Group held its Kodiak Sciences (KOD) position steady in Q2 2026 at 1,014 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

KBC Group first reported a position in KOD in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • KBC Group held 1,014 shares of Kodiak Sciences worth $40K as of Q2 2026.
  • KBC Group left its Kodiak Sciences share count unchanged in Q2 2026.
  • Kodiak Sciences made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1773 holding.
  • KBC Group first reported a position in Kodiak Sciences in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.